Lauren P. Silvernail, CFO, CBO & Secretary at Revance Therapeutics, Inc. (RVNC), sold 1,793 shares at $20.20 ($36K) on 2017-05-22, disclosed to the SEC on 2017-05-24.
Seasonal sale ($36k) by CFO, CBO & Secretary — this insider has traded RVNC in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| EOLS | SELL | 2022-03-10 | $198K | — | Filing → |
| EOLS | SELL | 2021-08-12 | $320K | — | Filing → |
| EOLS | SELL | 2021-01-26 | $20K | — | Filing → |